A Novel Role of E-Cadherin-Based Adherens Junctions in Neoplastic Cell Dissemination
Overview
Affiliations
Using confocal microscopy, we analyzed the behavior of IAR-6-1, IAR1170, and IAR1162 transformed epithelial cells seeded onto the confluent monolayer of normal IAR-2 epithelial cells. Live-cell imaging of neoplastic cells stably expressing EGFP and of normal epithelial cells stably expressing mKate2 showed that transformed cells retaining expression of E-cadherin were able to migrate over the IAR-2 epithelial monolayer and invade the monolayer. Transformed IAR cells invaded the IAR-2 monolayer at the boundaries between normal cells. Studying interactions of IAR-6-1 transformed cells stably expressing GFP-E-cadherin with the IAR-2 epithelial monolayer, we found that IAR-6-1 cells established E-cadherin-based adhesions with normal epithelial cells: dot-like dynamic E-cadherin-based adhesions in protrusions and large adherens junctions at the cell sides and rear. A comparative study of a panel of transformed IAR cells that differ by their ability to form E-cadherin-based AJs, either through loss of E-cadherin expression or through expression of a dominant negative E-cadherin mutant, demonstrated that E-cadherin-based AJs are key mediators of the interactions between neoplastic and normal epithelial cells. IAR-6-1DNE cells expressing a dominant-negative mutant form of E-cadherin with the mutation in the first extracellular domain practically lost the ability to adhere to IAR-2 cells and invade the IAR-2 epithelial monolayer. The ability of cancer cells to form E-cadherin-based AJs with the surrounding normal epithelial cells may play an important role in driving cancer cell dissemination in the body.
Uruski P, Mikula-Pietrasik J, Tykarski A, Ksiazek K Biomolecules. 2024; 14(11).
PMID: 39595551 PMC: 11592052. DOI: 10.3390/biom14111374.
Unique Cohorts of Salivary Gland Cancer Cells as an Model of Circulating Tumor Cells.
Mincy C, Revelt L, Carter K, Reed D, Joy A J Maxillofac Oral Surg. 2024; 23(4):896-908.
PMID: 39118911 PMC: 11303642. DOI: 10.1007/s12663-024-02250-0.
Ilnitskaya A, Litovka N, Rubtsova S, Zhitnyak I, Gloushankova N Cells. 2024; 13(9.
PMID: 38727316 PMC: 11083118. DOI: 10.3390/cells13090780.
Dayoub A, Fokin A, Lomakina M, James J, Plays M, Jacquin T Int J Mol Sci. 2023; 24(1).
PMID: 36613756 PMC: 9820126. DOI: 10.3390/ijms24010313.
Alexandrova A, Lomakina M Front Pharmacol. 2022; 13:962652.
PMID: 36278174 PMC: 9582651. DOI: 10.3389/fphar.2022.962652.